SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects
Status:
Recruiting
Trial end date:
2022-12-28
Target enrollment:
Participant gender:
Summary
The principal aim of this study is to obtain safety and tolerability data when AQ280 is
administered orally as single and multiple doses to healthy subjects. This information,
together with the pharmacokinetic (PK) data, will help establish the doses and dosing regimen
suitable for future studies in patients.